We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BioShield II Bill Includes Patent Incentives for Brand Firms
BioShield II Bill Includes Patent Incentives for Brand Firms
May 3, 2005
Brand firms would receive tax incentives and intellectual property protections for developing bioterror antidotes under new biodefense legislation introduced in the Senate -- a situation that concerns generic industry groups like the Generic Pharmaceutical Association (GPhA).